Jiangsu Hengrui Pharmaceuticals (01276) invested 51.8592 million yuan to repurchase 985,800 A-shares on August 6.
Hengrui Medicine (01276) announced that on August 6, 2026, it spent RMB 51.8592 million to repurchase 985,800 A-shares.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on August 6, 2026, it invested RMB 51,859,200 to repurchase 985,800 A-shares.
Related Articles
Meta (META.US) and BlackRock, Inc. (BLK.US) face a $14 billion data center "insurance black hole": only 3.2% coverage obtained, lenders may incur billions in risks.
US Stock Market Move | The concept stocks of storage chips surged, with Sandisk (SNDK.US) rising by 6%.
TL NATURAL GAS (08536) announced its interim results, reporting a loss of 4.807 million yuan during the period, an increase of 79.43% year-on-year.
Meta (META.US) and BlackRock, Inc. (BLK.US) face a $14 billion data center "insurance black hole": only 3.2% coverage obtained, lenders may incur billions in risks.
US Stock Market Move | The concept stocks of storage chips surged, with Sandisk (SNDK.US) rising by 6%.
TL NATURAL GAS (08536) announced its interim results, reporting a loss of 4.807 million yuan during the period, an increase of 79.43% year-on-year.
RECOMMEND
